Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies Supports Expanded Access to Rare Disease Therapies in Latin America  

Regulatory approvals in 14 countries expand treatment options for sickle cell disease, Guillain-Barré syndrome and myasthenia gravis Approvals align with the historic World Health Assembly resolution on rare diseases. 16 September 2025 -- Colorado, US -- In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM),...

Terumo BCT and PwC Belgium Join Forces to Break Barriers in Access to Advanced Cell and Gene Therapies 

2 September 2025 -- Brussels, Belgium -- Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, and PwC Belgium today announce a new collaboration focused on driving equitable and sustainable access to Advanced Therapy Medicinal Products (ATMPs). As part of the bold initiative, the companies will host a flagship event in Brussels, convening...
Old Belfast Road Millbrook Larne BT40 2SH

44(0) 1452 729292